In thyroid tumors, elucidation of the interaction between BRAF and Wnt signaling is just beginning to emerge, and BRAF mutations in PTC appear to cause downregulation of E-cadherin, potentially promoting Wnt signaling via a mechanism involving increased levels of cytoplasmic β-catenin [66]. This evidence concerns the gene BRAF and thyroid tumor.